Yuchao Jiang,Cheng Luo,Jijun Wang,Lena Palaniyappan,Xiao Chang,Shitong Xiang,Jie Zhang,Mingjun Duan,Huan Huang,Christian Gaser,Kiyotaka Nemoto,Kenichiro Miura,Ryota Hashimoto,Lars T Westlye,Genevieve Richard,Sara Fernandez-Cabello,Nadine Parker,Ole A Andreassen,Tilo Kircher,Igor Nenadić,Frederike Stein,Florian Thomas-Odenthal,Lea Teutenberg,Paula Usemann,Udo Dannlowski,Tim Hahn,Dominik Grotegerd,Susanne Meinert,Rebekka Lencer,Yingying Tang,Tianhong Zhang,Chunbo Li,Weihua Yue,Yuyanan Zhang,Xin Yu,Enpeng Zhou,Ching-Po Lin,Shih-Jen Tsai,Amanda L Rodrigue,David Glahn,Godfrey Pearlson,John Blangero,Andriana Karuk,Edith Pomarol-Clotet,Raymond Salvador,Paola Fuentes-Claramonte,María Ángeles Garcia-León,Gianfranco Spalletta,Fabrizio Piras,Daniela Vecchio,Nerisa Banaj,Jingliang Cheng,Zhening Liu,Jie Yang,Ali Saffet Gonul,Ozgul Uslu,Birce Begum Burhanoglu,Aslihan Uyar Demir,Kelly Rootes-Murdy,Vince D Calhoun,Kang Sim,Melissa Green,Yann Quidé,Young Chul Chung,Woo-Sung Kim,Scott R Sponheim,Caroline Demro,Ian S Ramsay,Felice Iasevoli,Andrea de Bartolomeis,Annarita Barone,Mariateresa Ciccarelli,Arturo Brunetti,Sirio Cocozza,Giuseppe Pontillo,Mario Tranfa,Min Tae M Park,Matthias Kirschner,Foivos Georgiadis,Stefan Kaiser,Tamsyn E Van Rheenen,Susan L Rossell,Matthew Hughes,William Woods,Sean P Carruthers,Philip Sumner,Elysha Ringin,Filip Spaniel,Antonin Skoch,David Tomecek,Philipp Homan,Stephanie Homan,Wolfgang Omlor,Giacomo Cecere,Dana D Nguyen,Adrian Preda,Sophia Thomopoulos,Neda Jahanshad,Long-Biao Cui,Dezhong Yao,Paul M Thompson,Jessica A Turner,Theo G M van Erp,Wei Cheng,ENIGMA Schizophrenia Consortium,ZIB Consortium,Jianfeng Feng

Abstract:Machine learning can be used to define subtypes of psychiatric conditions based on shared clinical and biological foundations, presenting a crucial step toward establishing biologically based subtypes of mental disorders. With the goal of identifying subtypes of disease progression in schizophrenia, here we analyzed cross-sectional brain structural magnetic resonance imaging (MRI) data from 4,291 individuals with schizophrenia (1,709 females, age=32.5 years±11.9) and 7,078 healthy controls (3,461 females, age=33.0 years±12.7) pooled across 41 international cohorts from the ENIGMA Schizophrenia Working Group, non-ENIGMA cohorts and public datasets. Using a machine learning approach known as Subtype and Stage Inference (SuStaIn), we implemented a brain imaging-driven classification that identifies two distinct neurostructural subgroups by mapping the spatial and temporal trajectory of gray matter (GM) loss in schizophrenia. Subgroup 1 (n=2,622) was characterized by an early cortical-predominant loss (ECL) with enlarged striatum, whereas subgroup 2 (n=1,600) displayed an early subcortical-predominant loss (ESL) in the hippocampus, amygdala, thalamus, brain stem and striatum. These reconstructed trajectories suggest that the GM volume reduction originates in the Broca's area/adjacent fronto-insular cortex for ECL and in the hippocampus/adjacent medial temporal structures for ESL. With longer disease duration, the ECL subtype exhibited a gradual worsening of negative symptoms and depression/anxiety, and less of a decline in positive symptoms. We confirmed the reproducibility of these imaging-based subtypes across various sample sites, independent of macroeconomic and ethnic factors that differed across these geographic locations, which include Europe, North America and East Asia. These findings underscore the presence of distinct pathobiological foundations underlying schizophrenia. This new imaging-based taxonomy holds the potential to identify a more homogeneous sub-population of individuals with shared neurobiological attributes, thereby suggesting the viability of redefining existing disorder constructs based on biological factors.

Response to: Significance and stability of deep learning-based identification of subtypes within major psychiatric disorders. Molecular Psychiatry (2022)

Redefining and subtyping of major depression based on brain functional connectivity signatures with high generalization: an ensemble hybrid framework

Correction: Identifying and validating subtypes within major psychiatric disorders based on frontal–posterior functional imbalance via deep learning

Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.

Identification of psychiatric disorder subtypes from functional connectivity patterns in resting-state electroencephalography

Subphenotyping Depression Using Machine Learning and Electronic Health Records

Neuropsychiatric Disorder Subtyping Via Clustered Deep Learning Classifier Explanations

Multi-modal deep learning from imaging genomic data for schizophrenia classification

NetMoST: A network-based machine learning approach for subtyping schizophrenia using polygenic SNP allele biomarkers

Cross-species machine learning improves diagnostic classification of human psychiatric disorders

Two neurostructural subtypes: results of machine learning on brain images from 4,291 individuals with schizophrenia

Sparse deep neural networks on imaging genetics for schizophrenia case–control classification

Incorporating clinical, genomic profiles and polygenic risk scores for the subtyping of depressive disorders

Identification of transdiagnostic psychiatric disorder subtypes using unsupervised learning

Unveiling the potential of machine learning in schizophrenia diagnosis: A meta-analytic study of task-based neuroimaging data

Individualized gray matter morphological abnormalities uncover two robust transdiagnostic biotypes

Exploring Schizophrenia Classification Through Multimodal MRI and Deep Graph Neural Networks: Unveiling Brain Region-Specific Weight Discrepancies and Their Association With Cell-Type Specific Transcriptomic Features

An integrated machine learning framework for a discriminative analysis of schizophrenia using multi-biological data

Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction

Neuroimaging-based variability in subtyping biomarkers for psychiatric heterogeneity

A Novel Machine-learning Model to Classify Schizophrenia Using Methylation Data Based on Gene Expression